Advertisement
Screener

INNOVIVA, INC. (INVA) Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31)

2.9 / 5 stars · 69/119 Roast Me

INNOVIVA, INC. Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31)

INNOVIVA, INC. (INVA) had Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) of $93.00 thousand as of 2013-06-30, per its 10-Q filed 2013-08-01.

Discontinued › Notes › Investments

us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLosses1 · last filed 2013-08-01

  • 2013-06-30: Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) $93.00K.
  • 2013-03-31: Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) $29.00K.
  • 2012-12-31: Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) $28.00K.
  • 2012-09-30: Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) $8.00K.
Period endAvailable-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31)
2013-06-30$93.00K
10-Q · filed 2013-08-01
2013-03-31$29.00K
10-Q · filed 2013-05-01
2012-12-31$28.00K
10-Q · filed 2013-08-01
2012-09-30$8.00K
10-Q · filed 2012-10-31
2012-06-30$123.00K
10-Q · filed 2012-08-01
2012-03-31$17.00K
10-Q · filed 2012-05-02
2011-12-31$19.00K
10-K · filed 2013-02-26
2010-12-31$16.00K
10-K · filed 2012-02-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
ArriVent BioPharma, Inc. (AVBP)United States$1.485B-10.25
Ultragenyx Pharmaceutical Inc. (RARE)United States$1.456B-5.62
OMEROS CORP (OMER)United States$1.456B5.50
ANAPTYSBIO, INC (ANAB)United States$1.546B-60.20
Kailera Therapeutics, Inc. (KLRA)United States$1.552B
Syndax Pharmaceuticals Inc (SNDX)United States$1.606B-8.82
Oric Pharmaceuticals, Inc. (ORIC)United States$1.367B-8.00
Rapport Therapeutics, Inc. (RAPP)United States$1.623B-14.56
Stoke Therapeutics, Inc. (STOK)United States$1.630B-9.82
Xeris Biopharma Holdings, Inc. (XERS)United States$1.632B-80.10